# OnCo record arrow-thyroid (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/arrow-thyroid/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "arrow-thyroid", "NCT03037385" ;
  schema:name "ARROW (thyroid cohorts)"@en ;
  schema:description "ARROW is the single-arm study behind the second RET inhibitor's thyroid approvals."@en ;
  schema:url <https://onco.cc/trials/arrow-thyroid/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03037385>, <https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00120-0/fulltext>, <https://doi.org/10.1016/S1470-2045(21)00247-3>, <https://www.nice.org.uk/guidance/ta812> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2017-03-17" ;
  onco:cancers <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/ret-fusion-nsclc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/ret/> ;
  onco:drugs <https://onco.cc/drugs/pralsetinib/> ;
  onco:companies <https://onco.cc/companies/blueprint-medicines/> ;
  onco:trials <https://onco.cc/trials/nct03157128/>, <https://onco.cc/trials/libretto-431/> .